<DOC>
	<DOCNO>NCT00430651</DOCNO>
	<brief_summary>This trial compare effectiveness Docetaxel without Carboplatin second line chemotherapy patient Non-Small Cell Lung Cancer , treat previously Docetaxel .</brief_summary>
	<brief_title>Docetaxel Carboplatin Versus Docetaxel Second Line Treatment Patients With Non-Small-Cell Lung Carcinoma ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologically cytologically confirm NSCLC . ECOG Performance Status 02 . No previous treatment Docetaxel . Measurable Disease . Brain metastasis treat radiotherapy stable asymptomatic . Adequate liver kidney bone marrow function . Patients must able understand nature study give write informed consent . Active cardiac disease : unstable angina onset angina within last 3 month , myocardial infarction within 6 month , congestive heart failure &gt; class II , cardiac ventricular arrhythmia require antiarrhythmic therapy . Women pregnant lactating . Unknown HIV , chronic hepatitis B chronic hepatitis C infection . Serious neurologic psychiatric disease . Second primary malignancy within past 5 year , except nonmelanomas skin cancer situ carcinoma cervix . Active uncontrolled infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Non Small Cell Lung Cancer</keyword>
	<keyword>2nd line chemotherapy</keyword>
	<keyword>Docetaxel</keyword>
</DOC>